Return to study ST001312 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
CL 68:2; [M-2H](2-); CL(18:1/16:0/18:1/16:0) ME306235 CL 18:1/16:0/18:1/16:0 --Reversed phase NEGATIVE ION MODE
CL 70:4; [M-2H](2-); CL(16:0/18:1/18:1/18:2) ME306082 CL 16:0/18:1/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:5; [M-2H](2-); CL(18:0/18:2/18:1/18:2) ME306229 CL 18:0/18:2/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:1/18:2) ME306127 CL 18:1/18:2/18:1/18:2 --Reversed phase NEGATIVE ION MODE
CL 72:6; [M-2H](2-); CL(18:1/18:2/18:2/18:1) ME306038 CL 18:1/18:2/18:2/18:1 --Reversed phase NEGATIVE ION MODE
CL 72:8; [M-2H](2-); CL(18:2/18:2/18:2/18:2) ME306203 CL 18:2/18:2/18:2/18:2 --Reversed phase NEGATIVE ION MODE
CL 74:2; [M-2H](2-); CL(18:0/18:1/18:0/20:1) ME306050 CL 18:0/18:1/18:0/20:1 --Reversed phase NEGATIVE ION MODE
CL 78:11; [M-2H](2-); CL(16:0/18:0/22:5/22:6) ME306183 CL 16:0/18:0/22:5/22:6 --Reversed phase NEGATIVE ION MODE


  logo